{"transactions":[{"id":2020018,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-13T17:34:51.000Z","date":"2023-02-09","kind":"grant","acquired":true,"shares":27400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 27,400 shares of the Issuer's Common Stock, which will vest in full on February 9, 2024, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":27400,"derivative":{"exercise_price":14.7,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":27400},"source":{"system":"sec-edgar","filing":"0000899243-23-004799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000089924323004799/doc4.xml","form_type":"4"}},{"id":2265771,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-18T16:05:34.000Z","date":"2022-05-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 25,000 shares of the Issuer's Common Stock, which will vest in full on May 16, 2023, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":25000,"derivative":{"exercise_price":2.64,"expiration_date":"2032-05-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-22-018587","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000089924322018587/doc4.xml","form_type":"4"}},{"id":2661171,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-21T17:30:18.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service with the Issuer, the RSUs will vest as to 100% of the shares underlying the RSUs on the earlier of (i) June 17, 2022 or (ii) the date of the first annual meeting following June 17, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,000 unvested RSUs."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001415889-21-003120","document":"form4-06212021_050601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000141588921003120/form4-06212021_050601.xml","form_type":"4"}},{"id":2740944,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-23T17:27:24.000Z","date":"2021-04-21","kind":"sale","acquired":false,"shares":850,"price":27.6,"value":23460.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-016878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000089924321016878/doc4.xml","form_type":"4"}},{"id":2745205,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-19T16:51:19.000Z","date":"2021-04-15","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 12,500 shares of the Issuer's Common Stock, one third of which will vest on April 15, 2022, with the remaining two thirds vesting in equal monthly installments over the following two years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":12500,"derivative":{"exercise_price":24.16,"expiration_date":"2031-04-15","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-21-016233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000089924321016233/doc4.xml","form_type":"4"}},{"id":2975354,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-18T19:09:20.000Z","date":"2020-11-16","kind":"other","acquired":true,"shares":850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Capital III to its members."}],"balance_after":850,"source":{"system":"sec-edgar","filing":"0000899243-20-031486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000089924320031486/doc4.xml","form_type":"4"}},{"id":2975353,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-11-18T19:09:20.000Z","date":"2020-11-16","kind":"other","acquired":false,"shares":850000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Longitude Venture Partners III, L.P. (\"Longitude Venture III\") to its general and limited partners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Longitude Venture III. Longitude Capital Partners III, LLC (\"Longitude Capital III\") is the general partner of Longitude Venture III. The Reporting Person is a member of Longitude Capital III and may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":1750877,"source":{"system":"sec-edgar","filing":"0000899243-20-031486","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000089924320031486/doc4.xml","form_type":"4"}},{"id":3083687,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-14T20:08:31.000Z","date":"2020-07-10","kind":"purchase","acquired":true,"shares":109090,"price":27.5,"value":2999975.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 10, 2020, Longitude Venture Partners III, L.P. (\"Longitude Venture III\") purchased 109,090 shares of the Issuer's common stock at a price of $27.50 per share in the Issuer's follow-on public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Longitude Venture III. Longitude Capital Partners III, LLC (\"Longitude Capital III\") is the general partner of Longitude Venture III. The Reporting Person is a member of Longitude Capital III and may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":2600877,"source":{"system":"sec-edgar","filing":"0000899243-20-019122","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000089924320019122/doc4.xml","form_type":"4"}},{"id":3083688,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-14T17:03:29.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 7,000 shares of the Issuer's Common Stock, which will vest in full on June 22, 2021, subject to the Reporting Person's continued service to the Issuer through such date."}],"balance_after":7000,"derivative":{"exercise_price":24.29,"expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000899243-20-019091","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000089924320019091/doc4.xml","form_type":"4"}},{"id":3097619,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-29T21:48:13.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service with the Issuer, the RSUs will vest as to 100% of the shares underlying the RSUs on the earlier of (i) June 25, 2021 or (ii) the date of the first annual meeting following June 25, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,000 unvested RSUs."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001104659-20-078310","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000110465920078310/a4.xml","form_type":"4"}},{"id":3180762,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-07T16:15:29.000Z","date":"2020-04-05","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 7,000 shares of the Issuer's Common Stock, one third of which will vest on April 5, 2021, with the remaining two thirds vesting in equal monthly installments over the following two years, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":7000,"derivative":{"exercise_price":21.4,"expiration_date":"2030-04-05","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000899243-20-010402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000089924320010402/doc4.xml","form_type":"4"}},{"id":3209000,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-16T07:59:59.000Z","date":"2020-03-13","kind":"purchase","acquired":true,"shares":2534854,"price":7.89,"value":19999998.06,"ownership":{"direct":false,"nature":"By Longitude Venture Partners IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Longitude Capital Partners IV, LLC (\"LCP IV\") is the general partner of Longitude Venture Partners IV, L.P. (\"LVP IV\") and may be deemed to have voting, investment and dispositive power with respect to such securities. Patrick G. Enright, Juliet Tammenoms Bakker are the managing members of LCP IV. Each of LCP IV, Mr. Enright, Ms. Tammenoms Bakker and the Reporting Person (a member of the Issuer's board of directors) disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose."}],"balance_after":2534854,"source":{"system":"sec-edgar","filing":"0001179110-20-003675","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000117911020003675/edgar.xml","form_type":"4"}},{"id":3373041,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-11-13T19:04:14.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":11916667,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-6.217 basis immediately prior the closing of the Issuer's initial public offering on November 13, 2019 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-6.217 basis immediately prior the closing of the Issuer's initial public offering on November 13, 2019 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-6.217 basis immediately prior the closing of the Issuer's initial public offering on November 13, 2019 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by Longitude Venture III. Longitude Capital Partners III, LLC (\"Longitude Capital III\") is the general partner of Longitude Venture III. The Reporting Person is a member of Longitude Capital III and may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1916787},"source":{"system":"sec-edgar","filing":"0000899243-19-027222","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000089924319027222/doc4.xml","form_type":"4"}},{"id":3373040,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-13T19:04:14.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":1916787,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Preferred Stock automatically converted into shares of the Issuer's common stock on a one-for-6.217 basis immediately prior the closing of the Issuer's initial public offering on November 13, 2019 and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by Longitude Venture III. Longitude Capital Partners III, LLC (\"Longitude Capital III\") is the general partner of Longitude Venture III. The Reporting Person is a member of Longitude Capital III and may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":2491787,"source":{"system":"sec-edgar","filing":"0000899243-19-027222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000089924319027222/doc4.xml","form_type":"4"}},{"id":3373039,"issuer":{"id":73682,"kind":"organization","name":"89bio, Inc.","symbol":"ETNB"},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-13T19:04:14.000Z","date":"2019-11-11","kind":"purchase","acquired":true,"shares":575000,"price":16,"value":9200000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 11, 2019, Longitude Venture Partners III, L.P. (\"Longitude Venture III\") purchased 575,000 shares of the Issuer's common stock at a price of $16.00 per share in the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held directly by Longitude Venture III. Longitude Capital Partners III, LLC (\"Longitude Capital III\") is the general partner of Longitude Venture III. The Reporting Person is a member of Longitude Capital III and may be deemed to share voting, investment and dispositive power with respect to these securities. The Reporting Person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of his pecuniary interests therein."}],"balance_after":575000,"source":{"system":"sec-edgar","filing":"0000899243-19-027222","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000089924319027222/doc4.xml","form_type":"4"}},{"id":3497361,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-07T16:02:08.000Z","date":"2019-06-05","kind":"grant","acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 5, 2019 and vests with respect to 1/12th of the shares underlying the option at the end of each successive one-month period thereafter."}],"balance_after":21000,"derivative":{"exercise_price":5.35,"expiration_date":"2029-06-04","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001104659-19-034522","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000110465919034522/a4.xml","form_type":"4"}},{"id":3794514,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T16:46:17.000Z","date":"2018-10-05","kind":"purchase","acquired":true,"shares":606060,"price":8.25,"value":4999995.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held by Longitude Venture Partners II, L.P. The Reporting Person is a member of Longitude Capital Partners II, LLC, the general partner of Longitude Venture Partners II, L.P., and may be deemed to share voting and investment power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":2877006,"source":{"system":"sec-edgar","filing":"0001179110-18-012105","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000117911018012105/edgar.xml","form_type":"4"}},{"id":3894080,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-14T16:47:29.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":12960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 12, 2018 and vests in equal monthly installments until the one-year anniversary of the date of grant and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":12960,"derivative":{"exercise_price":13.73,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":12960},"source":{"system":"sec-edgar","filing":"0001179110-18-008526","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000117911018008526/edgar.xml","form_type":"4"}},{"id":4251190,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2017-07-26T16:31:39.000Z","date":"2017-07-25","kind":"exercise","acquired":false,"shares":10707985,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Preferred Stock converted into Common Stock on a 5.2083-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Preferred Stock converted into Common Stock on a 5.2083-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Preferred Stock converted into Common Stock on a 5.2083-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"These shares were held by Longitude Venture Partners II, L.P. The Reporting Person is a member of Longitude Capital Partners II, LLC, the general partner of Longitude Venture Partners II, L.P., and may be deemed to share voting and investment power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2055946},"source":{"system":"sec-edgar","filing":"0001179110-17-010704","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000117911017010704/edgar.xml","form_type":"4"}},{"id":4251189,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-26T16:31:39.000Z","date":"2017-07-25","kind":"purchase","acquired":true,"shares":215000,"price":15,"value":3225000.0,"ownership":{"direct":false,"nature":"By Longitude Venture Partners II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners II, L.P. The Reporting Person is a member of Longitude Capital Partners II, LLC, the general partner of Longitude Venture Partners II, L.P., and may be deemed to share voting and investment power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Includes 215,000 shares of Common Stock acquired by Longitude Venture Partners, II, L.P in the Issuer's initial public offering."}],"balance_after":2270946,"source":{"system":"sec-edgar","filing":"0001179110-17-010704","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000117911017010704/edgar.xml","form_type":"4"}},{"id":4251188,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-26T16:31:39.000Z","date":"2017-07-25","kind":"exercise","acquired":true,"shares":2055946,"ownership":{"direct":false,"nature":"By Longitude Venture Partners II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock converted into Common Stock on a 5.2083-for-one-basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by Longitude Venture Partners II, L.P. The Reporting Person is a member of Longitude Capital Partners II, LLC, the general partner of Longitude Venture Partners II, L.P., and may be deemed to share voting and investment power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":2055946,"source":{"system":"sec-edgar","filing":"0001179110-17-010704","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000117911017010704/edgar.xml","form_type":"4"}},{"id":4253315,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":116989,"kind":"person","name":"Grunberg Gregory","position":1,"cik":"0001711080","reported_name":"Grunberg Gregory","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-21T16:20:12.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":12960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted, effective on July 19, 2017 and vests over one year, with 8.33% of the shares underlying the option vesting on August 19, 2017, and an addition 8.33% of the shares underlying the option vesting at the end of each successive one-month period thereafter."}],"balance_after":12960,"derivative":{"exercise_price":15,"expiration_date":"2027-07-18","underlying":"Common Stock","underlying_shares":12960},"source":{"system":"sec-edgar","filing":"0001179110-17-010593","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711080/000117911017010593/edgar.xml","form_type":"4"}}]}